Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04925830
Other study ID # 34_DT_Biofeedback
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 18, 2020
Est. completion date June 17, 2021

Study information

Verified date October 2021
Source University Hospital, Geneva
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Inhibitory control refers to the conscious and voluntary suppression of predominant responses when they are automatic, inappropriate, or incorrect. Inhibitory control plays a key role in self-regulation and self-control behaviors in many different areas of everyday life. During aging, their decline would impact executive functioning and mental health. Recently, physiological training methods including heart rate variability biofeedback (HRV-BF), based on heart rate and respiration measurements, and hemoencephalography biofeedback (nirHEG NF), based on the hemodynamic response of some prefrontal regions, have proven to have a positive impact on executive functions. In this study, subjects of the experimental group were exposed to biofeedback training during 10 sessions, once a week, and their results compared to those of the control group, which did not receive biofeedback training. This study aims to explore the impact of training that combines two innovative techniques, such as heart rate variability biofeedback and hemoencephalography biofeedback on the inhibitory control of older adults. We expect positive effects of biofeedback training on the inhibition tasks and the targeted physiological parameters. Primary objective - We intend to demonstrate that heart rate variability biofeedback training coupled with hemoencephalography biofeedback training can be effective methods to counteract the decline of inhibitory control in older adults. Secondary objective - We intend to demonstrate that heart rate variability biofeedback and hemoencephalography biofeedback can effectively increase heart rate variability and blood flood oxygenation.


Description:

This is a pilot, randomized controlled study that aims to explore the effects of the combination of two interventions, HRV-BF and nirHEG neurofeedback, on the inhibitory control of healthy older adults. The study is thus designed with two parallel groups: the experimental group will receive sessions of HRV-BF and nirHEG NF whereas the control group will receive sessions in which visual biofeedback will be disabled. The three tasks used in the present study to appraise inhibitory control are Go/no Go, The Arrow task and Stroop task whereas impulsive behaviour will be evaluated with the UPPS scale. In addition, the feeling of self-efficacity and the attitude toward stereotypes will also be assessed with respectively the Self-efficacity scale and l'Echelle du moral. All these tasks will be administered at pretest and posttest intervention. Procedures Healthy older adults will be recruited by public advertisements and flyers posted at the Universities of Geneva, in sport clubs and various seniors associations. After a verbal consent and an initial telephone interview (anamnestic questionnaire and F-TICS-m-Telephone Interview for Cognitive Status questionnaire, Vercambre et al.,2010), the eligible participants will be asked to attend a first visit during which written informed consent will be obtained. After confirmation of eligibility and enrolment, the 50 selected participants will be randomly assigned to an experimental or a control group each group counting about 25 subjects. First, both study groups will be evaluated with a battery of inhibition and psychological testing. Then, the experimental group (n=25) will receive 10 biofeedback training sessions (heart rate variability plus hemoencephalography neurofeedback, 1 hour session, once a week for 10 weeks. The control group (n=25) will receive sessions in which visual biofeedback will be disabled. Both study groups will be evaluated at 2 points - pre and post training on inhibitory control, impulsivity, heart rate variability levels, hemodynamic response, feeling of self-efficacity and attitude toward aging.


Recruitment information / eligibility

Status Completed
Enrollment 39
Est. completion date June 17, 2021
Est. primary completion date June 17, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years to 80 Years
Eligibility Inclusion Criteria: - Healthy adults - 65 to 80 years old - Native French speakers or speaking French for over 5 years Exclusion Criteria: - Adults who report <27 on TICS (Telephone Interview for Cognitive Status questionnaire) - Adults that report a history of major neurological or psychiatric illness in the present or the past - Use of psychotropic drugs

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Heart rate variability biofeedback; haemoncephalography biofeedback
Ten 25-minute weekly heart rate variability biofeedback and 30 minute haemoencephalogrphy biofeedback sessions

Locations

Country Name City State
Switzerland Center for the Interdisciplinary Study of Gerontology and Vulnerabilities (CIGEV) Geneva

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Geneva

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in interference score (milliseconds) Between group post-pre interference score change (reaction time) in Arrow task Pre-intervention (week 1) - Post-intervention (week 13)
Primary Change in inhibitory response (milliseconds) Between group post-pre reaction time change in GO no GO Pre-intervention (week 1) - Post-intervention (week 13)
Primary Change in interference score (seconds) Between group post-pre interference score in Stroop task Pre-test (week 1) - Posttest (week 13)
Secondary Heart rate variability changes Between group post-pre change in heart rate variability values (RMSSD, LF, HF) HRV-baseline (week 2) - HRV-posttest (week 13)
See also
  Status Clinical Trial Phase
Completed NCT03990129 - Pharmacokinetic Interactions of Metamizole (Dipyrone) in Healthy Subjects Phase 1
Recruiting NCT04299971 - Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients Phase 4
Active, not recruiting NCT04831294 - Effects of Cannabidiol (CBD) on the Brain N/A
Completed NCT03472703 - Effect of Consumption on Cognitive Processes N/A
Completed NCT03341247 - Brain Mechanisms of Overeating in Children
Completed NCT05232422 - Yoga Practice, Stress and Cognitive Performance N/A
Completed NCT02717260 - Inhibition Transcranial Random Noise Stimulation N/A
Recruiting NCT05009784 - Effects of Natural Sounds on Attention Restoration in Noisy Environment N/A